PL374827A1 - Preparat farmaceutyczny zawierający związek benzoimidazolu w mieszaninie z celulozą mikrokrystaliczną oraz sposób jego otrzymywania - Google Patents

Preparat farmaceutyczny zawierający związek benzoimidazolu w mieszaninie z celulozą mikrokrystaliczną oraz sposób jego otrzymywania

Info

Publication number
PL374827A1
PL374827A1 PL03374827A PL37482703A PL374827A1 PL 374827 A1 PL374827 A1 PL 374827A1 PL 03374827 A PL03374827 A PL 03374827A PL 37482703 A PL37482703 A PL 37482703A PL 374827 A1 PL374827 A1 PL 374827A1
Authority
PL
Poland
Prior art keywords
microcrystalline cellulose
benzimidazole compound
preparation
compound mixed
pharmaceutical preparation
Prior art date
Application number
PL03374827A
Other languages
English (en)
Other versions
PL208130B1 (pl
Inventor
Frank Muskulus
Peter Kraass
Andrea Burgenmeister
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10235475A external-priority patent/DE10235475B4/de
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of PL374827A1 publication Critical patent/PL374827A1/pl
Publication of PL208130B1 publication Critical patent/PL208130B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL374827A 2002-08-02 2003-07-16 Preparat farmaceutyczny zawierający związek benzoimidazolu w mieszaninie z celulozą mikrokrystaliczną oraz sposób jego otrzymywania PL208130B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40007102P 2002-08-02 2002-08-02
DE10235475A DE10235475B4 (de) 2002-08-02 2002-08-02 Arzneimittel mit einer Benzimidazolverbindung im Gemisch mit mikrokristalliner Cellulose und Verfahren zu deren Herstellung

Publications (2)

Publication Number Publication Date
PL374827A1 true PL374827A1 (pl) 2005-10-31
PL208130B1 PL208130B1 (pl) 2011-03-31

Family

ID=31716591

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374827A PL208130B1 (pl) 2002-08-02 2003-07-16 Preparat farmaceutyczny zawierający związek benzoimidazolu w mieszaninie z celulozą mikrokrystaliczną oraz sposób jego otrzymywania

Country Status (15)

Country Link
US (1) US7732474B2 (pl)
EP (1) EP1524967B1 (pl)
JP (1) JP2005536527A (pl)
AT (1) ATE388695T1 (pl)
AU (1) AU2003244647B2 (pl)
BR (1) BR0313173A (pl)
CA (1) CA2494716A1 (pl)
DE (1) DE60319707T2 (pl)
ES (1) ES2299710T3 (pl)
NO (1) NO20051018L (pl)
PL (1) PL208130B1 (pl)
PT (1) PT1524967E (pl)
RU (1) RU2332237C2 (pl)
WO (1) WO2004014345A1 (pl)
ZA (1) ZA200500324B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US20050214371A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
WO2006026829A1 (en) * 2004-09-09 2006-03-16 Metelli Pty Ltd Stable paste composition of enteric coated acid labile active agent and use thereof
EP1785135A1 (en) * 2005-11-10 2007-05-16 Laboratorios Del Dr. Esteve, S.A. New stabilized galenic formulations comprising lansoprazole and their preparation
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
CN101500541B (zh) 2006-08-11 2011-06-15 旭化成化学株式会社 含有水难溶性药物的球状素颗粒的制造方法
RU2414889C2 (ru) * 2007-11-16 2011-03-27 Общество С Ограниченной Ответственностью "Технология Лекарств" Фармацевтическая композиция для лечения язвы желудка и двенадцатиперстной кишки в форме твердых желатиновых капсул, содержащая рабепразол или его производные, и способ ее получения
US8911787B2 (en) * 2008-02-26 2014-12-16 Ranbaxy Laboratories Limited Stable oral benzimidazole compositions and process of preparation thereof
EP2319504A1 (en) * 2009-11-07 2011-05-11 Laboratorios Del. Dr. Esteve, S.A. Pharmaceutical solid dosage form
WO2012171540A1 (en) * 2011-06-15 2012-12-20 Bene-Arzneimittel Gmbh Suppository comprising pantoprazole comprised in pellets with a cellulose core
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
WO2017061621A1 (ja) * 2015-10-07 2017-04-13 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
JP6168673B2 (ja) 2015-10-07 2017-07-26 協和発酵キリン株式会社 アリールアルキルアミン化合物含有医薬組成物
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3292862A1 (en) 2016-09-07 2018-03-14 Sandoz Ag Omeprazole formulations

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
JPH0733659A (ja) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd 抗潰瘍剤含有製剤
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
MX9600857A (es) * 1994-07-08 1997-06-28 Astra Ab Forma de dosificacion i en tabletas, con unidades multiples.
ES2094694B1 (es) * 1995-02-01 1997-12-16 Esteve Quimica Sa Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
CH687810A5 (de) * 1995-05-24 1997-02-28 Mepha Ag Pelletformulierung mit Omeprazol.
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
DE19626045C2 (de) 1996-06-28 1998-12-03 Klinge Co Chem Pharm Fab Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
SI0991407T2 (en) * 1997-03-13 2005-10-31 Hexal Ag Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
ES2137862B1 (es) * 1997-07-31 2000-09-16 Intexim S A Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6228400B1 (en) 1999-09-28 2001-05-08 Carlsbad Technology, Inc. Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
EP1108425B1 (en) 1999-12-16 2005-06-08 Laboratorio Medinfar-Produtos Farmaceuticos, S.A. New stable multi-unitary pharmaceutical preparations containing substituted benzimidazoles

Also Published As

Publication number Publication date
US20050129760A1 (en) 2005-06-16
HK1072195A1 (en) 2005-08-19
AU2003244647A1 (en) 2004-02-25
JP2005536527A (ja) 2005-12-02
RU2005102814A (ru) 2005-12-20
RU2332237C2 (ru) 2008-08-27
PT1524967E (pt) 2008-04-03
CA2494716A1 (en) 2004-02-19
PL208130B1 (pl) 2011-03-31
DE60319707T2 (de) 2008-07-17
BR0313173A (pt) 2007-07-17
AU2003244647B2 (en) 2008-04-17
EP1524967B1 (en) 2008-03-12
NO20051018L (no) 2005-02-24
US7732474B2 (en) 2010-06-08
DE60319707D1 (de) 2008-04-24
ES2299710T3 (es) 2008-06-01
ZA200500324B (en) 2006-07-26
WO2004014345A1 (en) 2004-02-19
ATE388695T1 (de) 2008-03-15
EP1524967A1 (en) 2005-04-27

Similar Documents

Publication Publication Date Title
PT1524967E (pt) Preparação farmacêutica contendo um composto de benzimidazole misturado com celulose microcristalina e método para a sua preparação.
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
NZ597260A (en) Formulations for parenteral delivery of compounds and uses thereof comprising methylnaltrexone
TW200510375A (en) New compounds
UA96449C2 (en) Stable laquinimod preparations
TW200512206A (en) 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amion]-propionic acid ethylester-methanesulfonate and its use as a medicament
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
GEP20084468B (en) Gamma-d crystalline form of ivabradin hydrochloride, process for its preparation and pharmaceutical compositions containing it
IL164440A0 (en) New pharmaceutical composition containing fibanserin polymorph a
AP1787A (en) Novel perindopril salt and pharmaceutical compositions containing same.
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
TW200606149A (en) Crystalline polymorph of bazedoxifene acetate
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
UA122762C2 (uk) Пероральна композиція 9-[(2,2-диметилпропіламіно)-метил]-міноцикліну або його солі, тверда пресована дозована форма, композиція для ін'єкцій, застосування та спосіб приготування фармацевтичної композиції
SI1746980T1 (sl) Farmacevtska dozirna oblika ki obsega pelete kot tudi postopek za njeno pripravo
MXPA05013758A (es) Composiciones farmaceuticas que incluyen una antihistamina y un estimulante y uso de las mismas.
MX2008001645A (es) Composiciones de fexofendina en suspension farmaceutica oral.
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
TR201907729T4 (tr) Bir anti-çekirdekleştirici ajan içeren farmasötik bileşim.
TR200504890T1 (tr) Benipidin hidroklorür içeren farmasötik bileşim
PT1730144E (pt) Compostos de 1,4,8-triaza-espiro[4.5]decan-2-ona substituídos
IL165220A0 (en) Novel compounds, their use and preparation
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MY135460A (en) Method of stimulating hair growth using benzopyrans
MXPA05009686A (es) Composicion farmaceutica comprendiendo acido 5-metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico.

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20110716